Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

近日，美国食品药品监督管理局（FDA）正式批准了由吉利德（Gilead）公司研发的全新艾滋病病毒（HIV）预防药物——来那卡帕韦（Lenacapavir）。这款 ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

编者按：美国食品药品管理局（FDA）于当地时间6月18日批准了吉利德科学公司（Gilead Sciences, Inc.）的注射用HIV-1衣壳抑制剂Yeztugo（来那帕韦 ...

红枫湾APP： firstwordpharma.com消息，默沙东 (也译为默克）的一款长效（ 每月1次 ） 口服 HIV预防药物也宣布进入后期（III期）试验阶段，即将为HIV PrEP（暴露前预防）再添新选择。

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

The World Health Organisation (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a year ...

距离lenacapavir用于HIV预防在美国获批仅8个工作日，这一国际领先的创新药物就在博鳌乐城实现了“全球同步”准入，以“零时差”完成从海外获批到 ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

The introduction of a revolutionary drug, Lenacapavir, is poised to alter the landscape of healthcare across sub-Saharan ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...